Alternative splicing is a critical mechanism that generates a vast number of mRNA and protein isoforms from a relatively small number of human genes. Unlike promoter activity, which primarily regulates transcript levels, alternative splicing alters the structure of transcripts and their encoded proteins. It is estimated that at least 25% of alternative exons regulate transcript abundance through nonsense-mediated decay (NMD). Molecular studies show that alternative splicing influences protein binding properties, intracellular localization, enzymatic activity, protein stability, and posttranslational modifications. The effects range from complete loss of function to subtle changes, often observed in most cases. Alternative splicing factors regulate multiple pre-mRNAs, and recent findings indicate that specific splicing factors regulate pre-mRNAs with coherent biological functions. This suggests that alternative splicing coordinates physiologically meaningful changes in protein isoform expression and is a key mechanism in generating the complex proteome of multicellular organisms. Alternative splicing is highly prevalent in humans, with 59% of genes on chromosome 22 and 74% of all human genes being alternatively spliced. The human neurexin3 gene can generate 1728 transcripts, while the Drosophila DSCAM gene can generate 38,016 isoforms. Alternative splicing occurs in all tissues, with the highest prevalence in brain cells. It is also observed in evolutionarily distinct species, indicating its importance throughout evolution. The number of publications on alternative splicing has increased significantly, from 16 in 1985 to 1073 in 1998, with over 1000 publications per year since then. The mechanism of splice-site selection involves regulatory proteins such as SR and hnRNPs, which bind to splicing regulatory elements. These proteins interact with RNA and other proteins to facilitate splicing. Alternative splicing events can be classified into five basic patterns: cassette exons, alternative 5' and 3' splice sites, mutually exclusive cassette exons, and retained introns. These events can alter the coding sequence and affect protein function. Alternative splicing is regulated by various factors, including phosphorylation, which influences splicing site selection. Alternative splicing can introduce stop codons, leading to nonsense-mediated decay (NMD), which can regulate transcript expression. It can also add new protein domains, affecting binding properties, intracellular localization, enzymatic activity, and protein stability. For example, alternative splicing can alter the binding affinity of proteins to ligands, influence intracellular localization, and modify enzymatic activity. It can also affect the stability of proteins by introducing domains subject to posttranslational modification. Alternative splicing can change ion-channel properties, affecting ion permeability and channel function. It can also influence mRNA function by altering RNA stability and targeting mRNAs to specific subcellular locations. Examples of coordinated changes in biological systems include the regulation of muscle contractions,Alternative splicing is a critical mechanism that generates a vast number of mRNA and protein isoforms from a relatively small number of human genes. Unlike promoter activity, which primarily regulates transcript levels, alternative splicing alters the structure of transcripts and their encoded proteins. It is estimated that at least 25% of alternative exons regulate transcript abundance through nonsense-mediated decay (NMD). Molecular studies show that alternative splicing influences protein binding properties, intracellular localization, enzymatic activity, protein stability, and posttranslational modifications. The effects range from complete loss of function to subtle changes, often observed in most cases. Alternative splicing factors regulate multiple pre-mRNAs, and recent findings indicate that specific splicing factors regulate pre-mRNAs with coherent biological functions. This suggests that alternative splicing coordinates physiologically meaningful changes in protein isoform expression and is a key mechanism in generating the complex proteome of multicellular organisms. Alternative splicing is highly prevalent in humans, with 59% of genes on chromosome 22 and 74% of all human genes being alternatively spliced. The human neurexin3 gene can generate 1728 transcripts, while the Drosophila DSCAM gene can generate 38,016 isoforms. Alternative splicing occurs in all tissues, with the highest prevalence in brain cells. It is also observed in evolutionarily distinct species, indicating its importance throughout evolution. The number of publications on alternative splicing has increased significantly, from 16 in 1985 to 1073 in 1998, with over 1000 publications per year since then. The mechanism of splice-site selection involves regulatory proteins such as SR and hnRNPs, which bind to splicing regulatory elements. These proteins interact with RNA and other proteins to facilitate splicing. Alternative splicing events can be classified into five basic patterns: cassette exons, alternative 5' and 3' splice sites, mutually exclusive cassette exons, and retained introns. These events can alter the coding sequence and affect protein function. Alternative splicing is regulated by various factors, including phosphorylation, which influences splicing site selection. Alternative splicing can introduce stop codons, leading to nonsense-mediated decay (NMD), which can regulate transcript expression. It can also add new protein domains, affecting binding properties, intracellular localization, enzymatic activity, and protein stability. For example, alternative splicing can alter the binding affinity of proteins to ligands, influence intracellular localization, and modify enzymatic activity. It can also affect the stability of proteins by introducing domains subject to posttranslational modification. Alternative splicing can change ion-channel properties, affecting ion permeability and channel function. It can also influence mRNA function by altering RNA stability and targeting mRNAs to specific subcellular locations. Examples of coordinated changes in biological systems include the regulation of muscle contractions,